APTOF
Price
$0.81
Change
-$0.00 (-0.00%)
Updated
Jun 27 closing price
Capitalization
2.03M
XLO
Price
$0.68
Change
-$0.00 (-0.00%)
Updated
Jun 27 closing price
Capitalization
35.21M
38 days until earnings call
Interact to see
Advertisement

APTOF vs XLO

Header iconAPTOF vs XLO Comparison
Open Charts APTOF vs XLOBanner chart's image
Aptose Biosciences
Price$0.81
Change-$0.00 (-0.00%)
Volume$21.78K
Capitalization2.03M
Xilio Therapeutics
Price$0.68
Change-$0.00 (-0.00%)
Volume$348.96K
Capitalization35.21M
APTOF vs XLO Comparison Chart in %
Loading...
APTOF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
XLO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
APTOF vs. XLO commentary
Jun 30, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is APTOF is a Hold and XLO is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 30, 2025
Stock price -- (APTOF: $0.81 vs. XLO: $0.68)
Brand notoriety: APTOF and XLO are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: APTOF: 228% vs. XLO: 21%
Market capitalization -- APTOF: $2.03M vs. XLO: $35.21M
APTOF [@Biotechnology] is valued at $2.03M. XLO’s [@Biotechnology] market capitalization is $35.21M. The market cap for tickers in the [@Biotechnology] industry ranges from $299.85B to $0. The average market capitalization across the [@Biotechnology] industry is $2.3B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

APTOF’s FA Score shows that 0 FA rating(s) are green whileXLO’s FA Score has 0 green FA rating(s).

  • APTOF’s FA Score: 0 green, 5 red.
  • XLO’s FA Score: 0 green, 5 red.
According to our system of comparison, XLO is a better buy in the long-term than APTOF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

APTOF’s TA Score shows that 4 TA indicator(s) are bullish while XLO’s TA Score has 2 bullish TA indicator(s).

  • APTOF’s TA Score: 4 bullish, 2 bearish.
  • XLO’s TA Score: 2 bullish, 5 bearish.
According to our system of comparison, APTOF is a better buy in the short-term than XLO.

Price Growth

APTOF (@Biotechnology) experienced а -15.46% price change this week, while XLO (@Biotechnology) price change was -1.92% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.13%. For the same industry, the average monthly price growth was +31.22%, and the average quarterly price growth was +12.91%.

Reported Earning Dates

XLO is expected to report earnings on Aug 06, 2025.

Industries' Descriptions

@Biotechnology (+4.13% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
XLO($35.2M) has a higher market cap than APTOF($2.03M). APTOF YTD gains are higher at: 261.008 vs. XLO (-29.288). APTOF has higher annual earnings (EBITDA): -20.53M vs. XLO (-55.26M). XLO has more cash in the bank: 89.1M vs. APTOF (4.7M). XLO has less debt than APTOF: XLO (7.86M) vs APTOF (8.98M). XLO has higher revenues than APTOF: XLO (9.27M) vs APTOF (0).
APTOFXLOAPTOF / XLO
Capitalization2.03M35.2M6%
EBITDA-20.53M-55.26M37%
Gain YTD261.008-29.288-891%
P/E RatioN/AN/A-
Revenue09.27M-
Total Cash4.7M89.1M5%
Total Debt8.98M7.86M114%
FUNDAMENTALS RATINGS
APTOF: Fundamental Ratings
APTOF
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
89
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
56
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
APTOFXLO
RSI
ODDS (%)
Bullish Trend 3 days ago
89%
N/A
Stochastic
ODDS (%)
Bullish Trend 3 days ago
89%
Bullish Trend 3 days ago
85%
Momentum
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
90%
MACD
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
62%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
90%
Advances
ODDS (%)
Bullish Trend 3 days ago
80%
N/A
Declines
ODDS (%)
N/A
Bearish Trend 3 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
80%
N/A
Aroon
ODDS (%)
N/A
Bearish Trend 3 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
APTOF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
XLO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
KRC34.790.19
+0.55%
Kilroy Realty Corp
LEN110.210.40
+0.36%
Lennar Corp
LC11.970.02
+0.17%
LendingClub Corp
DRCT0.54-0.02
-3.10%
Direct Digital Holdings
DEFT2.79-0.10
-3.46%
DEFI Technologies Inc

APTOF and

Correlation & Price change

A.I.dvisor tells us that APTOF and WHWK have been poorly correlated (+29% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that APTOF and WHWK's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To APTOF
1D Price
Change %
APTOF100%
+0.49%
WHWK - APTOF
29%
Poorly correlated
+1.58%
XLO - APTOF
27%
Poorly correlated
-0.62%
LCTX - APTOF
26%
Poorly correlated
-3.02%
ORMP - APTOF
25%
Poorly correlated
-0.92%
CRIS - APTOF
24%
Poorly correlated
-2.25%
More

XLO and

Correlation & Price change

A.I.dvisor tells us that XLO and APTOF have been poorly correlated (+29% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that XLO and APTOF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To XLO
1D Price
Change %
XLO100%
-0.62%
APTOF - XLO
29%
Poorly correlated
+0.49%
AVTX - XLO
27%
Poorly correlated
+0.42%
ITOS - XLO
24%
Poorly correlated
-0.70%
GBIO - XLO
24%
Poorly correlated
-15.40%
VTGN - XLO
24%
Poorly correlated
-3.90%
More